Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content. If you have any issues relating to the topics here, please call the MS-UK Helpline on 0800 7830 518.


 

Cerebrospinal fluid levels of soluble CD27 may predict progression from clinically isolated syndrome (CIS) to multiple sclerosis, researchers reported.

In a Dutch study of 77 CIS patients,...

Healthcare providers frequently assess multiple sclerosis patients for the development of other health conditions, such as depression, anxiety, pain and sleep disturbance, according to results of...

Lack of physical activity and a poor diet may be the most common risk factors for poor health and survival in patients with multiple sclerosis, according to a study.

The research, “...

The MultipleMS Consortium has been granted €15M by the EU Horizon 2020 to improve the treatment of multiple sclerosis using personalised medicine.

The EU Horizon 2020 has kicked off the...

Researchers, using camels as an inspiration, have finally developed antibodies against a group of proteins known as metalloproteinases (MMPs), which are involved in the pathology of diseases that...

A rare and powerful type of immune cell has been discovered in the meninges around the brain, suggesting the cells may play a critical but previously unappreciated role in battling Alzheimer's,...

Investigation into voltage-operated calcium channels may contribute to the development of improved treatment options for patients with multiple sclerosis and other neurodegenerative diseases. MS...

The U.S. Food and Drug Administration (FDA) has extended its review of Roche's multiple sclerosis drug Ocrevus by three months to March 28, the Swiss drugmaker said recently.

Roche is...

A leak of a protein called haemoglobin from damaged red blood cells may be associated with brain shrinkage in multiple sclerosis.
This is the conclusion of a team from Imperial College...

Ibudilast (MN-166) has shown enough promise as a treatment for progressive multiple sclerosis that its U.S. phase 2b trial (NCT01982942) should continue, the U.S. National Institute of Health’s...

Pages